Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Zomedica Pharmaceuticals (ZOM – Research Report) today and set a price target ...

We currently have no ZOM Stock Split History on this stock.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

after hours • as of 7 Feb, 08:00 pm EST ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...